Download
s00702-021-02343-x.pdf 914,28KB
WeightNameValue
1000 Titel
  • Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters
1000 Autor/in
  1. Wabbels, Bettina |
  2. Yaqubi, Ali |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-05-08
1000 Erschienen in
1000 Quellenangabe
  • 128(6):793-802
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00702-021-02343-x |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205881/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Validation of the new hemifacial spasm (HFS) questionnaire 'HFS score' that captures both clinical (HFS clinical) and health-related quality of life (HRQOL) parameters (HFS subjective) in one tool and comparison with a global HRQOL questionnaire. Cross sectional, prospective validation study including 143 subjects (62 HFS patients and 81 healthy volunteers) from the University Eye Hospital Bonn. Patients were interviewed with the new HFS score and the SF-12 questionnaire prior to and 3 weeks after Botulinum neurotoxin A (BoNT-A) injection. All HRQOL-related questions (HFS subjective) were answered on a visual analogue scale (VAS) ranging from 0 (no complaints) to 100% (maximum complaints) by the patients themselves. Reproducibility was tested in a study extension with 10 patients by repeat interviews (telephone/personal). The new HFS score questionnaire provided a reliable clinical assessment and demonstrated that BoNT-A therapy significantly reduced frequency and severity of eye and cheek spasms (p < 0.001; Wilcoxon test). Relevant aspects of HRQOL of HFS patients were assessed with high accuracy and sensitivity. Significant improvements were achieved after BoNT-A injection in five out of eight HRQOL parameters (p ≤ 0.02; Wilcoxon test). Cronbach's alpha of 0.818 demonstrated good internal consistency. Telephone survey provided comparable results to personal interviews. This new sensitive and specific HFS score seems a reliable instrument to monitor BoNT therapy and customize it to the needs of the individual HFS patient-in clinical studies and daily clinical practice.
1000 Sacherschließung
lokal Hemifacial Spasm/drug therapy [MeSH]
lokal Surveys and Questionnaires [MeSH]
lokal Neurology and Preclinical Neurological Studies - Original Article
lokal Quality of life
lokal Reproducibility of Results [MeSH]
lokal Quality of Life [MeSH]
lokal Questionnaire
lokal Humans [MeSH]
lokal Botulinum toxin
lokal Cross-Sectional Studies [MeSH]
lokal Hemifacial spasm
lokal Botulinum Toxins, Type A/therapeutic use [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-7767-114X|https://frl.publisso.de/adhoc/uri/WWFxdWJpLCBBbGk=
1000 Hinweis
  • DeepGreen-ID: bfc4b2fa1c8b49f781e25e471ea171bd ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6446560.rdf
1000 Erstellt am 2023-04-28T13:30:31.571+0200
1000 Erstellt von 322
1000 beschreibt frl:6446560
1000 Zuletzt bearbeitet 2023-10-20T18:32:24.701+0200
1000 Objekt bearb. Fri Oct 20 18:32:24 CEST 2023
1000 Vgl. frl:6446560
1000 Oai Id
  1. oai:frl.publisso.de:frl:6446560 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source